Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14.
N Engl J Med. 2022.
PMID: 35833805
Free PMC article.
Clinical Trial.
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort.
Patil A, Shobha V, Shenoy P, S C, Kumar S, Daware M, Haridas V, Janardana R, Pinto B, Kodishala C, Ramaswamy S, S N, Jain V, Singh YP, Singhai S, C S, Jois R, Rao VK, Dharmapalaiah C, Kn S, Balebail D.
Patil A, et al.
Lupus. 2023 Apr;32(4):560-564. doi: 10.1177/09612033231155837. Epub 2023 Feb 2.
Lupus. 2023.
PMID: 36731873
Free PMC article.
On analysing the COVID-19 positive versus negative cohort during the study period, male gender (adjusted RR 3.72, 95% C.I. 1.85,7.51) and diabetes (adjusted RR 2.94, 95% C.I. 1.28, 6.79) emerged as the strongest risk factors for COVID-19, in the adjusted analysis. . …
On analysing the COVID-19 positive versus negative cohort during the study period, male gender (adjusted RR 3.72, 95% C.I. 1.85,7.51) …
Item in Clipboard
Cite
Cite